Trends of Readmissions of Atopic Dermatitis Patients in the United States: A 9‐year Longitudinal Analysis of the Nationwide Readmission Database

2021 ◽  
Author(s):  
E. Edigin ◽  
Z. El‐Amir ◽  
F. Wani ◽  
A. Kichloo ◽  
P.O Eseaton
Keyword(s):  
United States ◽  
Atopic Dermatitis ◽  
Longitudinal Analysis ◽  
The United States ◽  
Nationwide Readmission Database

Pedagogy Reconsidered in a Multimodal Blended Environment

2010 ◽  
pp. 299-316
Author(s):  
Barbara O'Byrne
Keyword(s):  
United States ◽  
Distance Education ◽  
Blended Learning ◽  
Longitudinal Analysis ◽  
The United States ◽  
Course Delivery ◽  
Learner Centered ◽  
The Impact ◽  
Blended Course ◽  
Depth Interviews

Blended course delivery has wide applications across diverse educational settings. By definition, it is multimodal and involves multiple delivery formats. However, scant research has examined the impact of multimodal, blended delivery on university pedagogy. This chapter makes the case for close examination of the theoretical and pedagogical foundation of blended learning and proposes that research is needed to establish and validate the constructivist principles associated with blended learning. A longitudinal analysis of surveys and in-depth interviews with instructors from a distance education graduate school in the United States identified and contextualized features of learner-centered pedagogy linked to blended learning.

15112 Epidemiology of atopic dermatitis in children aged 6-11 years: A cross-sectional Study in the United States, Canada, Europe, and Japan

2020 ◽  
Vol 83 (6) ◽  
pp. AB142
Author(s):  
Jonathan I. Silverberg ◽  
Abhijit Gadkari ◽  
Eric L. Simpson ◽  
Stephan Weidinger ◽  
Paola Mina-Osorio ◽  
...  
Keyword(s):  
United States ◽  
Atopic Dermatitis ◽  
The United States ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional

Weekend Emergency and Outpatient Visits for Atopic Dermatitis in the United States

Dermatitis ◽  
2020 ◽  
Vol 31 (5) ◽  
pp. e57-e58
Author(s):  
Partik Singh ◽  
Ziyou Ren ◽  
Jonathan I. Silverberg
Keyword(s):  
United States ◽  
Atopic Dermatitis ◽  
The United States ◽  
Outpatient Visits

scholarly journals Nonspecific Chest Pain and 30-Day Unplanned Readmissions in the United States (From the Nationwide Readmission Database)

2019 ◽  
Vol 123 (8) ◽  
pp. 1343-1350 ◽  
Author(s):  
Chun Shing Kwok ◽  
Purvi J. Parwani ◽  
David L. Fischman ◽  
Ritu Thamman ◽  
Jassim al Suwaidi ◽  
...  
Keyword(s):  
United States ◽  
Chest Pain ◽  
The United States ◽  
Nationwide Readmission Database

scholarly journals Hospitalization and Combined Use of Opioids, Benzodiazepines, and Muscle Relaxants in the United States

2019 ◽  
Vol 55 (5) ◽  
pp. 286-291
Author(s):  
Jonathan H. Watanabe ◽  
Jincheng Yang
Keyword(s):  
United States ◽  
Logistic Regression ◽  
Longitudinal Analysis ◽  
Muscle Relaxant ◽  
The United States ◽  
Muscle Relaxants ◽  
Medical Expenditure ◽  
Benzodiazepine Use ◽  
Opioid Users ◽  
Triple Threat

Introduction: Concurrent opioid and benzodiazepine use (“double-threat”) and double-threat and muscle relaxant use (“triple-threat”) are postulated to increase morbidity versus opioids alone. Study objectives were to measure association between double- and triple-threat exposure and hospitalizations in a validated, nationally representative database of the United States. Methods: A retrospective cohort study was conducted using the 2013 and 2014 Medical Expenditure Panel Survey (MEPS) longitudinal dataset and affiliated Prescribed Medicines Files. Association between 2013 and 2014 double- and triple-threat exposures and outcome of hospitalizations compared to nonusers, opioid users, and all combinations were assessed via logistic regression. The cohort surveyed in MEPS has been weighted to be reflective of the actual US population in the years 2013 and 2014. Logistic regression applying the subject-level MEPS survey weights was performed to measure association via odds ratios (ORs) of medication exposures with the outcome of all-cause hospitalization. Study subjects were categorized into exposure groups as nonusers (nonuse of opioids, benzodiazepines, or muscle relaxants), opioid users, benzodiazepine users, muscle relaxant users, “double-threat” users, and “triple-threat” users. Analyses were conducted using RStudio® 1.1.5 (Boston, MA) with α level = 0.05 for all comparisons. Results: Opioids, benzodiazepines, and muscle relaxants were used in 11.9% (38.4 million), 4.2% (13.5 million), and 3.4% (10.9 million) lives of the United States in 2013, respectively. Double-threat prevalence rose from 1.6% to 1.9% from 2013 to 2014. Triple-threat prevalence remained unchanged at 0.53%. Compared to nonusers, triple-threat patients increased hospitalization probability with ORs of 8.52 (95% confidence interval [CI]: 8.50-8.55) in 2013, 5.06 (95% CI: 5.04-5.08) in 2014, and 4.61 (95% CI: 4.59-4.63) in the 2013-2014 longitudinal analysis. Compared to nonusers, double-threat patients increased hospitalization probability with ORs of 5.71 (95% CI: 5.69-5.72) in 2013, 11.47 (95% CI: 11.44-11.49) in 2014, and 5.59 (95% CI: 5.57-5.60) in the longitudinal analysis. Conclusion: Concurrent opioid and benzodiazepine use and opioid, benzodiazepine, and muscle relaxant use were associated with increased hospitalization likelihood. Amplified efforts in surveillance, prescribing, monitoring, and deprescribing for concurrent opioid, benzodiazepine, and muscle relaxant use are needed to reduce this public health concern.

Sign in / Sign up

Export Citation Format

Share Document